Key result
Aspirin is effective for acute treatment and secondary prevention of cardiovascular disease, but its use in primary prevention requires balancing benefits against potential side effects.
Why the study?
Does aspirin reduce mortality and recurrence of cardiovascular events in patients with or at risk of cardiovascular disease?
Population
Patients with or at risk of cardiovascular disease, including acute coronary syndrome, thrombotic stroke…
Design
Review
Authors
Loading...
Supports aspirin's secondary prevention role with primary prevention risk-benefit caution; confirms consensus while leaving optimal thresholds open.
Does aspirin reduce mortality and recurrence of cardiovascular events in patients with or at risk of cardiovascular disease?
Aspirin remains a cornerstone therapy for the acute treatment and secondary prevention of cardiovascular disease, though its use in primary prevention requires careful consideration of risks and benefits.
Dai et al. (2011) conducted a review in Cardiovascular disease. Aspirin was evaluated. Aspirin is effective for acute treatment and secondary prevention of cardiovascular disease, but its use in primary prevention requires balancing benefits against potential side effects.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: